Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:1668290rdf:typepubmed:Citationlld:pubmed
pubmed-article:1668290lifeskim:mentionsumls-concept:C0086418lld:lifeskim
pubmed-article:1668290lifeskim:mentionsumls-concept:C1749467lld:lifeskim
pubmed-article:1668290lifeskim:mentionsumls-concept:C0020852lld:lifeskim
pubmed-article:1668290lifeskim:mentionsumls-concept:C1280500lld:lifeskim
pubmed-article:1668290lifeskim:mentionsumls-concept:C0332621lld:lifeskim
pubmed-article:1668290lifeskim:mentionsumls-concept:C0449297lld:lifeskim
pubmed-article:1668290pubmed:issue1lld:pubmed
pubmed-article:1668290pubmed:dateCreated1992-8-24lld:pubmed
pubmed-article:1668290pubmed:abstractTextSerum concentrations of IgG may influence Fc receptor-mediated clearance of immune complexes. For instance, when 123I-labeled aggregates of human IgG (123I-AIgG), used as a model for soluble immune complexes, are administered to patients with systemic lupus erythematosus (SLE), there is an inverse correlation between the serum concentrations of IgG and the clearance and volume of distribution in steady state (Vss) of 123I-AIgG. To answer the question whether IgG has a direct effect on the clearance of immune complexes, we measured the elimination of 123I-AIgG in eight patients with hypogammaglobulinemia, before and after substitution with intravenous gammaglobulin (IVIG). As expected, raising IgG concentrations in these patients (by 6 g/l) caused a significant decrease of the Vss of 123I-AIgG. However, clearance of 123I-AIgG remained unchanged by IVIG. Thus, the results of this study offer no experimental evidence that raising concentrations of IgG influences the clearance of soluble immune complexes.lld:pubmed
pubmed-article:1668290pubmed:languageenglld:pubmed
pubmed-article:1668290pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1668290pubmed:citationSubsetIMlld:pubmed
pubmed-article:1668290pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1668290pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1668290pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1668290pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1668290pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1668290pubmed:statusMEDLINElld:pubmed
pubmed-article:1668290pubmed:monthMaylld:pubmed
pubmed-article:1668290pubmed:issn0141-2760lld:pubmed
pubmed-article:1668290pubmed:authorpubmed-author:CohenAAlld:pubmed
pubmed-article:1668290pubmed:authorpubmed-author:van FurthRRlld:pubmed
pubmed-article:1668290pubmed:authorpubmed-author:van der...lld:pubmed
pubmed-article:1668290pubmed:authorpubmed-author:GageA PAPlld:pubmed
pubmed-article:1668290pubmed:authorpubmed-author:van EsL ALAlld:pubmed
pubmed-article:1668290pubmed:authorpubmed-author:PauwelsE KEKlld:pubmed
pubmed-article:1668290pubmed:authorpubmed-author:HalmiKKlld:pubmed
pubmed-article:1668290pubmed:authorpubmed-author:BreedveldF...lld:pubmed
pubmed-article:1668290pubmed:authorpubmed-author:Evers-Schoute...lld:pubmed
pubmed-article:1668290pubmed:issnTypePrintlld:pubmed
pubmed-article:1668290pubmed:volume35lld:pubmed
pubmed-article:1668290pubmed:ownerNLMlld:pubmed
pubmed-article:1668290pubmed:authorsCompleteYlld:pubmed
pubmed-article:1668290pubmed:pagination9-15lld:pubmed
pubmed-article:1668290pubmed:dateRevised2004-11-17lld:pubmed
pubmed-article:1668290pubmed:meshHeadingpubmed-meshheading:1668290-...lld:pubmed
pubmed-article:1668290pubmed:meshHeadingpubmed-meshheading:1668290-...lld:pubmed
pubmed-article:1668290pubmed:meshHeadingpubmed-meshheading:1668290-...lld:pubmed
pubmed-article:1668290pubmed:meshHeadingpubmed-meshheading:1668290-...lld:pubmed
pubmed-article:1668290pubmed:meshHeadingpubmed-meshheading:1668290-...lld:pubmed
pubmed-article:1668290pubmed:meshHeadingpubmed-meshheading:1668290-...lld:pubmed
pubmed-article:1668290pubmed:meshHeadingpubmed-meshheading:1668290-...lld:pubmed
pubmed-article:1668290pubmed:meshHeadingpubmed-meshheading:1668290-...lld:pubmed
pubmed-article:1668290pubmed:meshHeadingpubmed-meshheading:1668290-...lld:pubmed
pubmed-article:1668290pubmed:meshHeadingpubmed-meshheading:1668290-...lld:pubmed
pubmed-article:1668290pubmed:meshHeadingpubmed-meshheading:1668290-...lld:pubmed
pubmed-article:1668290pubmed:year1991lld:pubmed
pubmed-article:1668290pubmed:articleTitleEffect of monomeric immunoglobulin G (IgG) on the clearance of soluble aggregates of IgG in man.lld:pubmed
pubmed-article:1668290pubmed:affiliationDepartment of Nephrology, University Hospital Leiden, The Netherlands.lld:pubmed
pubmed-article:1668290pubmed:publicationTypeJournal Articlelld:pubmed